SMTL ID : 8fgx.1

Cryo-EM structure of the STAR-0215 Fab in complex with active human plasma kallikrein

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

hetero-1-1-1-mer

Ligands

3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.1: 8 residues within 4Å: Chain C: G.374, G.375, T.376, N.377, N.514, I.515, Q.517 Ligands: NAG.2 1 PLIP interactions: 1 interactions with chain C Hydrogen bonds: C:N.377 NAG.2: 6 residues within 4Å: Chain C: N.434, S.436, D.437, N.514, I.515 Ligands: NAG.1 2 PLIP interactions: 2 interactions with chain C Hydrophobic interactions: C:I.515 Hydrogen bonds: C:D.437 NAG.3: 1 residues within 4Å: Chain C: N.475 1 PLIP interactions: 1 interactions with chain C Hydrogen bonds: C:N.475

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Bedian, V. et al., STAR-0215 is a Novel, Long-Acting Monoclonal Antibody Inhibitor of Plasma Kallikrein for the Potential Treatment of Hereditary Angioedema . J.Pharmacol.Exp.Ther. (2023)

Release Date

2023-09-06

Peptides

STAR-0215 Light chain: A
STAR-0215 Heavy chain: B
Plasma kallikrein light chain: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

STAR-0215 Light chain

STAR-0215 Heavy chain

Plasma kallikrein light chain